The latest closing stock price for CRISPR Therapeutics AG as of July 03, 2025 is 52.17.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,703 today, roughly 3 times their original investment - a 15.66% compound annual growth rate over 9 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 63.68, which is 22.1% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 30.04, which is 42.4% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 44.78.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,703 today, roughly 3 times their original investment - a 15.66% compound annual growth rate over 9 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 63.68, which is 22.1% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 30.04, which is 42.4% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 44.78.